Related references
Note: Only part of the references are listed.RELIABILITY OF THE TRIPLE-TIMED UP-AND-GO TEST
Donald B. Sanders et al.
MUSCLE & NERVE (2018)
LAMBERT-EATON MYASTHENIC SYNDROME: EPIDEMIOLOGY AND THERAPEUTIC RESPONSE IN THE NATIONAL VETERANS AFFAIRS POPULATION
Daniel C. Abenroth et al.
MUSCLE & NERVE (2017)
Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia
Nilay Thakkar et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Amifampridine phosphate (Firdapse®) is effective and safe in a phase 3 clinical trial in LEMS
Shin J. Oh et al.
MUSCLE & NERVE (2016)
02 Successful withdrawal of 3,4--Diaminopyridine: a report on six patients with Lambert Eaton Myasthenic Syndrome
M. N. M. Punter et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Minimal Detectable Change of the Timed Up & Go Test and the Dynamic Gait Index in People With Parkinson Disease
Sheau-Ling Huang et al.
PHYSICAL THERAPY (2011)
Practical aspects of 3,4-diaminopyridine treatment of the Lambert-Eaton myasthenic syndrome
H. Lundh et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Efficacy of 3,4-Diaminopyridine and Pyridostigmine in the Treatment of Lambert-Eaton Myasthenic Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
P. W. Wirtz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
3,4-DIAMINOPYRIDINE IS MORE EFFECTIVE THAN PLACEBO IN A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER DRUG STUDY IN LEMS
Shin J. Oh et al.
MUSCLE & NERVE (2009)
Reliability of measurements obtained with the Timed Up & Go Test in people with Parkinson disease
S Morris et al.
PHYSICAL THERAPY (2001)
A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome
DB Sanders et al.
NEUROLOGY (2000)
Share Paper
